CIK 0001127537
- Non-accelerated filer
- Smaller reporting company
Pulmonx Corp
Sign in to watch- Ticker
- LUNG
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-364-0400
- Business address
- 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- PULMONX
- 4 Open-market buy Director bought 2,500 shares at $40.00 ($100,000)
- 4 Open-market buy Director bought 2,222 shares at $44.12 ($98,035)
- 4 Open-market sale President and CEO sold 26,000 shares at an average $42.95 ($1,116,585)
- 4 Grant or award Chief Financial Officer acquired 17,600 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 17,600 shares (grant or award)
- 4 Grant or award Director acquired 2,810 shares (grant or award)
- 4 Grant or award Director acquired 2,810 shares (grant or award)
- 4 Grant or award General Counsel acquired 17,600 shares (grant or award)
- 4 Grant or award President and CEO acquired 45,600 shares (grant or award)
- 4 Grant or award Director acquired 2,810 shares (grant or award)
- 4 Grant or award Director acquired 2,810 shares (grant or award)
- 4 Grant or award Director acquired 2,810 shares (grant or award)
- 4 Open-market sale Chief Commercial Officer sold 4,797 shares at an average $40.88 ($196,085)
- 4 Open-market sale President and CEO sold 26,000 shares at an average $41.91 ($1,089,530)
- 4 Exercise or conversion Chief Commercial Officer acquired 49,428 shares (option exercise)
- 4 Open-market sale Chief Commercial Officer sold 4,797 shares at an average $40.70 ($195,247)
- 4 Open-market sale Chief Commercial Officer sold 4,797 shares at $43.24 ($207,422)
- 4 Open-market sale President and CEO sold 26,000 shares at an average $43.75 ($1,137,556)
- 5 Insider Annual Insider Trading Report
- 3/A Insider 3/A
Page 10 of 12 · 229 filings